| Literature DB >> 25241178 |
Maureen M Jonas1, Kathleen B Schwarz2, Regino Gonzalez-Peralta3, Steven Lobritto4, Jean P Molleston5, Karen F Murray6, Philip Rosenthal7, Jessica Wen8, Cynthia Wat9, Vedran Pavlovic9, Charles Warne9.
Abstract
Effects on linear growth were noted in children treated with peginterferon ± ribavirin in the Pediatric Study of Hepatitis C trial. Growth was further examined in a subset of patients followed for up to 6 years post-treatment. No long-term effects on height-for-age z scores were observed that could be attributed to hepatitis C virus treatment.Entities:
Mesh：
Substances：
Year: 2014 PMID： 25241178 DOI： 10.1016/j.jpeds.2014.08.010
Source DB: PubMed Journal: J Pediatr ISSN： 0022-3476 Impact factor: 4.406